{
    "clinical_study": {
        "@rank": "124275", 
        "arm_group": {
            "arm_group_label": "16-Week Exercise Program", 
            "arm_group_type": "Experimental", 
            "description": "Subjects to participate in 16-week3 supervised aerobic exercise 3 times per week.  Exercise sessions to last between 30 and 60 minutes."
        }, 
        "brief_summary": {
            "textblock": "This is an amendment to study posting NCT00970060. Based on preliminary results from that\n      study is was determined there needs to be a follow-up exercise intervention study.  This\n      study has two additional aims than the original study.  The objectives are to determine is a\n      prolonged exercise routine, 16-weeks, paired with refined measures of effectiveness\n      positively impact people with diabetic neuropathy."
        }, 
        "brief_title": "Pilot Study of Exercise and Peripheral Nerve Function in People With Diabetes - ENRGy2 Addendum", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Diabetic Neuropathy", 
        "condition_browse": {
            "mesh_term": "Diabetic Neuropathies"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 40-70\n\n          -  Type 2 diabetes\n\n          -  Peripheral neuropathy\n\n        Exclusion Criteria:\n\n          -  serious cardiac pathology such as recent myocardial infarction or heart surgery,\n             uncontrolled cardiac arryhthmia, hypertrophic cardiomyopathy symptomatic aortic\n             stenosis or heart failure, unstable angina, acute pulmonary embolus or myocarditis,\n             conduction abnormalities, or mitral valve prolapse\n\n          -  serious musculoskeletal problems that would limit ability to exercise\n\n          -  skin conditions, circulatory insufficiency, or open wounds in the leg that would\n             interfere with healing from the biopsy\n\n          -  open wounds on the weight bearing surface of the feet\n\n          -  not able to ambulate independently\n\n          -  stroke or other central nervous system pathology\n\n          -  stage 2 hypertension (resting blood pressure  > 160 systolic or > 100 diastolic)\n\n          -  lidocaine allergy\n\n          -  anticipated difficulty with blood clotting due to Coumadin(Warfarin) use or blood\n             clotting disorder\n\n          -  body weight > 450 lbs\n\n          -  inadequate cognition and communication abilities, defined as < 24 on the Mini Mental\n             Status Exam (MMSE)\n\n          -  pregnant or planning on becoming pregnant in the 18 weeks following enrollment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "19", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01764373", 
            "org_study_id": "ENRGy2 Addendum"
        }, 
        "intervention": {
            "arm_group_label": "16-Week Exercise Program", 
            "description": "Aerobic exercises in the program include cycle ergometers, treadmills, recumbent steppers and elliptical trainers.", 
            "intervention_name": "Aerobic Exercise", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pain", 
            "Fitness", 
            "Diabetes", 
            "Aerobic Exercise"
        ], 
        "lastchanged_date": "September 26, 2013", 
        "link": {
            "description": "Original Protocol Study Posting", 
            "url": "http://clinicaltrials.gov/ct2/show/NCT00970060"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Kansas City", 
                    "country": "United States", 
                    "state": "Kansas", 
                    "zip": "66160"
                }, 
                "name": "University of Kansas Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Pilot Study of Exercise and Peripheral Nerve Function in People With Diabetes - Exercise and Neuropathy Research Group v.2 (ENRGy2) Addendum", 
        "overall_official": {
            "affiliation": "University of Kansas", 
            "last_name": "Patricia Kluding, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Change in nerve function will be quantified using the Total Neuropathy Score (TNS). The TNS is a composite measure of peripheral nerve function that includes grading of signs/symptoms, nerve conduction studies, and quantitative sensory testing. We will not include proprioceptive testing in this project.", 
                "measure": "Change nerve function", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 16"
            }, 
            {
                "description": "Aerobic fitness will be assessed with a graded maximal exercise test as in the previous protocol with a metabolic cart and integrated ECG.", 
                "measure": "Change in aerobic fitness", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 16"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01764373"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Kansas", 
            "investigator_full_name": "Patricia Kluding, PhD", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Change will be measured after exercise intervention to see what effects exercise has on dermal and epidermal innervation.  Change measured via skin biopsy.", 
                "measure": "Change in cutaneous innervation", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 16"
            }, 
            {
                "description": "Measured as part of the aerobic fitness assessment.  Use of standardized protocol with total body recumbent stepped to be used to obtain the maximal workload.", 
                "measure": "Change in maximal workload", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 16"
            }, 
            {
                "description": "Pain will be measured using the Brief Pain Inventory Short Form for diabetic peripheral neuropathy. This scale has been specifically validated in this population and consists of 3 pain severity items and a 7-item pain interference scale.", 
                "measure": "Change in pain experienced", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 16"
            }
        ], 
        "source": "University of Kansas", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Kansas", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}